Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNMSF | AMGN | GILD | CELG | ILMN |
| Company | Genmab A/S | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 269.8700 | 273.45 | 67.47 | 108.01 | 121.97 |
| High | 283.5800 | 274.35 | 67.90 | 108.59 | 122.04 |
| Low | 265.3000 | 267.24 | 65.32 | 107.27 | 116.91 |
| Last | 269.8700 | 268.05 | 65.64 | 108.24 | 118.57 |
| Change | -9.7300 | -4.96 | -1.44 | +0.11 | -4.30 |
| % Change | -3.48% | -1.82% | -2.15% | +0.10% | -3.50% |
| Volume | 203 | 477,782 | 3,681,652 | 191,230,496 | 324,470 |
| 20-Day Average Volume | 684 | 2,081,018 | 6,256,755 | 16,188,930 | 1,482,877 |
| Previous Close | 279.6000 | 273.01 | 67.08 | 108.13 | 122.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 291.2798 | 270.62 | 68.70 | 108.17 | 125.48 |
| 20-Day Raw Stochastic | 44.02% | 25.21% | 2.92% | 63.25% | 9.29% |
| 20-Day Relative Strength | 45.85% | 43.40% | 29.01% | 64.69% | 39.59% |
| Weighted Alpha | -29.75 | +8.18 | -23.24 | +46.30 | -40.68 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 40% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 24% Sell | 24% Buy | 88% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.34% since 04/18/24 | +1.89% since 04/18/24 | -0.89% since 04/18/24 | -1.97% since 11/13/19 | +1.11% since 04/18/24 |
| Low | 265.3000 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 107.27 on 11/20/19 | 116.61 on 04/19/24 |
| High | 294.5400 on 04/23/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -5.97% since 03/25/24 | -4.67% since 03/25/24 | -9.66% since 03/25/24 | +5.14% since 10/18/19 | -11.99% since 03/25/24 |
| Low | 265.3000 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 310.5600 on 03/27/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +2.75% since 01/25/24 | -13.71% since 01/25/24 | -18.27% since 01/25/24 | +13.63% since 08/20/19 | -17.35% since 01/25/24 |
| Low | 262.0000 on 02/13/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 323.0180 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -0.74% since 10/25/23 | -1.64% since 10/25/23 | -16.35% since 10/25/23 | +14.14% since 05/20/19 | +3.56% since 10/25/23 |
| Low | 262.0000 on 02/13/24 | 249.70 on 10/31/23 | 65.32 on 04/25/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 334.3280 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,277,454 | 146,436,016 | 83,519,768 | 77,035,920 | 19,567,662 |
| Shares Outstanding, K | 65,370 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 2,392,030,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | 631,910,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 674,810,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | 90,250,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 1.01 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.63 on 02/14/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 24.50 | 14.67 | 9.97 | 10.99 | 143.06 |